Assessing the Safety and Ability of SG1002 to Overcome Deficits in Hydrogen Sulfide in Heart Failure Patients

NCT01989208 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Heart Failure

Interventions

OTHER: SG1002
OTHER: Placebo

Sponsor

Sulfagenix Australia Pty Ltd.